Objective: We examined the relationships between computed tomography (CT)-defined skeletal muscle parameters and the systemic inflammatory response (SIR) in patients with operable primary colorectal cancer (CRC). Background: Muscle depletion is characterized by a reduced muscle mass (myopenia) and increased infiltration by inter-and intramuscular fat (myosteatosis). It is recognized as a poor prognostic indicator in patients with cancer, but the underlying factors remain unclear. Methods: A total of 763 patients diagnosed with CRC undergoing elective surgical resection between 2006 and 2013 were included. Image analysis of CT scans was used to calculate Lumbar skeletal muscle index (LSMI), and mean muscle attenuation (MA). The SIR was quantified by the preoperative neutrophil to lymphocyte ratio (NLR) and albumin levels. Correlation and multivariate regression analysis was performed to identify independent relationships between patient SIR and muscle characteristics. Results: Patients with NLR > 3 had significantly lower LSMI and lower MA than those with NLR < 3 [LSMI ¼ 42.07 cm 2 m À2 vs 44.27 cm 2 m À2 (P ¼ 0.002) and MA ¼ 30.04 Hounsfield unit (HU) vs 28.36 HU (P ¼ 0.016)]. Multivariate logistic regression analysis showed that high NLR [odds ratio (OR) ¼ 1.78 (95% confidence interval [CI]: 1.29-2.45), P < 0.001] and low albumin [OR ¼ 1.80 (95% CI: 1.17-2.74), P ¼ 0.007] were independent predictors of reduced muscle mass. High NLR was significantly related with a low mean MA and hence myosteatosis [OR ¼ 1.60 (95% CI: 1.03-2.49), P ¼ 0.038]. Conclusions: These results highlight a direct association between myopenia, myosteatosis, and the host SIR in patients with operable CRC. A better understanding of factors that regulate muscle changes such as myopenia and myosteatosis may lead to the development of novel therapies that influence a more metabolically ''healthy'' skeletal muscle and potentially alter cancer outcomes.
C olorectal cancer (CRC) is the second leading cause of cancer mortality in the United Kingdom. 1 In determining prognosis, much emphasis has been placed upon tumor molecular biology, yet relatively little is known about the importance of host-related homeostatic factors in determining CRC outcome. Body composition (BC)-the proportion of fat, muscle, and bone in an individual patient-has been found to be associated with a greater risk of developing CRC in addition to an increased cancer-related mortality. 2, 3 Skeletal muscle depletion occurs primarily because of age and is a poor prognostic indicator in gastrointestinal malignancies. 4 Muscle depletion is characterized by reduction in muscle size and an increased infiltration by inter-and intramuscular fat, described as myosteatosis. 5, 6 Image-based analyses are central to BC assessment. 7 Crosssectional areas of visceral, subcutaneous, and intramuscular adipose tissues; psoas, paraspinal muscles; and muscles of the abdominal wall on computed tomography (CT) at the lumbar level correlate strongly with whole body tissues. 8 CT not only precisely quantifies muscle mass in vivo but also reliably assesses skeletal muscle fat content. 9, 10 To date, research on CT BC quantification techniques suggests that patients with a high visceral fat or depleted skeletal muscle mass have poorer functional capacity, greater chemotherapy toxicity, more rapid time to cancer progression and higher mortality in situations where weight loss and body mass index (BMI) lack predictive power. [11] [12] [13] [14] [15] Because of the multifactorial character of the condition, neither the time of onset of muscle loss or myosteatosis nor the exact etiology is known. Inactivity, age-related factors, anorexia, and unbalanced nutrition are proposed mechanisms that alter skeletal muscle. 16 There is also weak evidence that the systemic inflammatory response (SIR), already recognized, as a marker of poor prognosis in patients with gastrointestinal cancer, is associated with the cardinal features of muscle depletion such as decreased quality of life, or increased risk of morbidity and mortality. 17 Neutrophil to lymphocyte ratio (NLR) is calculated from a routine laboratory full blood count test and has been considered as a predictive prognostic factor for survival outcomes in CRC due to its performance and availability. The results of a recent meta-analysis indicate that pretreatment NLR can predict disease-free survival in patients undergoing primary resections for CRC and in patients undergoing liver metastasectomy or ablation. NLR has also a role in predicting progression-free survival in patients undergoing palliative treatments for CRC. 18 It is thought that a high NLR reflects increased systemic inflammatory changes in the host that are cancer promoting and thereby associated with a poorer prognosis. Hypoalbuminemia is the result of the combined effects of inflammation and inadequate protein and caloric intake in patients with chronic disease and has also been used as a marker of SIR. 19 Myosteatosis and low muscle mass have emerged as independent risk factors for mortality in cancer; however, the characteristics and pathogenesis of these features have not been resolved. This study aimed to determine whether CT-defined myopenia and myosteatosis (LSMI and MA) is associated with SIR expressed as NLR and albumin in patients with primary operable CRC.
METHODS

Patient Population
A total of 1477 consecutive patients undergoing CRC surgery at St Mark's Hospital, London, between January 2006 and December 2013 were identified from a prospective database. Patients with recorded height data, laboratory blood test data within 4 weeks of the staging CT scan, and preoperative staging of CT images stored and retrievable in an electronic format suitable for image analysis were included in the study. Exclusions were patients with disease recurrence confirmed preoperatively or at surgery and emergency cases. All prospectively recorded clinical and pathological data were revalidated from medical and pathology records. Data collected prospectively during the perioperative period (within 30 days of surgery) included age, sex, BMI, the American Society of Anaesthesiologists (ASA) physical status classification system, tumor site, histological grading, TNM stage [Union for International Cancer Control (UICC) 5 version], and the presence of vascular invasion on histopathology. Laboratory blood test data collected included preoperative albumin, neutrophil, and lymphocyte counts.
Computed Tomography Image Analysis
Images were retrieved from digital storage in the Picture Archiving and Communication System. Computed tomographic image analysis Slice-O-Matic V4.3 software (Tomovision, Montreal, Canada) was performed as described previously. 8 Briefly, total skeletal muscle and adipose tissue surface area (cm 2 ) were evaluated on a single image at the third lumbar vertebrae (L3) using Hounsfield unit (HU) thresholds of -29 to 150 for skeletal muscle, -150 to 50 for visceral adipose tissue, and -190 to -30 for subcutaneous adipose tissues. Visceral, subcutaneous fat area (VFA, SFA), and skeletal muscle area (SMA) or skeletal muscle index form the taxonomies used. The sum of skeletal cross-sectional muscle areas were normalized for stature (m 2 ) and reported as lumbar skeletal muscle index (LSMI) (cm 2 m À2 ). Mean muscle attenuation (MA) (HU) was reported for the whole muscle area at the third lumbar vertebra level. Reduced LSMI (myopenia) and low MA (myosteatosis) were defined using predefined sex-specific skeletal muscle index cut points. 20 The database is registered with the UK National Research Ethics Committee (reference number: 12/LO/1556), and local ethical committee approval was granted for this study (reference number: 12/088).
Statistical Analysis
SPSS v19.0 (IBM Corp, Armonk, NY) was used for statistical analysis. BC parameters are presented as median values and interquartile ranges (IQR) and are categorized into sexspecific groups. Grouping of the other variables was carried out using standard or previously published thresholds. Mann-Whitney and Fisher exact tests were used to test for differences in continuous and categorical variables, respectively. Univariate and multivariate logistic regression were used to assess the relationship between muscle depletion and myosteatosis and multiple categorical variables.
RESULTS
Patient Selection
Of 1477 consecutive patients undergoing surgical resection, 188 cases had a preoperative CT scan stored in a paper film form and therefore not suitable for analysis, 285 cases did not have blood test data or height data available at the time of CT scan and 163 had emergency surgery, 21 had recurrent disease at the time of surgery, and for 57 the CT analysis was not possible due to poor quality. Exclusion of these patients resulted in a sample size of 763 patients who had undergone an elective resection for CRC. Baseline clinicopathological characteristics of the cohort are shown in Table 1 . Median age was 69 [IQR: 60-76] years. The majority of patients (54.7%) had evidence of a preoperative SIR expressed as NLR > 3. 
Body Composition Parameters
The BC parameters of the patients are shown in Table 2 . There were no differences in BMI between sexes. Women had significantly more subcutaneous fat tissue than men expressed as L3 subcutaneous fat index [79.18 cm 2 m À2 versus 53.62 cm 2 m À2 (P < 0.001)]. Men had significantly more visceral fat tissue expressed as L3 visceral fat index [56.12 cm 2 m À2 vs 33.53 cm 2 m À2 (P < 0.001)] and more skeletal muscle tissues expressed as LSMI [46.61 cm 2 m À2 vs 37.90 cm 2 m À2 (P < 0.001)] than female patients. The median MA value for the male group was 30.66 HU, whereas the median MA for the female group was significantly lower at 27.53 HU (P < 0.001). Sex-specific differences were also recorded in the VFA/SFA and VFA/SMA ratios.
Body Composition and Inflammatory Response Markers
The relationships of BC parameters and SIR measures are shown in Table 3 . There were no differences between the SIR expressed as NLR and the L3 subcutaneous fat index, L3 visceral fat index, VFA/SFA, VFA/ SMA ratios, and the BMI. Patients with NLR > 3 had significantly lower LSMI and lower MA than those with NLR < 3 [LSMI ¼ 42.07 cm 2 m À2 vs 44.27 cm 2 m À2 (P ¼ 0.002) and MA ¼ 30.04 HU vs 28.36 HU (P ¼ 0.016)]. Patients with hypoalbuminemia had also significantly lower LSMI [40.24cm 2 m À2 vs 44.17 cm 2 m À2 , (P < 0.001)], MA [26.58 HU vs 30.31 HU (P < 0.001)], and L3 visceral index [43.77 cm 2 m À2 vs 49.83 cm 2 m À2 (P ¼ 0.03)] compared to patients with normal albumin levels. To further examine the relationship between SIR and levels of muscularity, sex-specific scatter plots of the associations were drawn. Correlations between NLR, albumin, and L3 skeletal muscle index remained significant.
Clinical, Pathological, and Inflammatory Predictors of Myopenia
To investigate whether SIR expressed, as NLR or albumin was associated with myopenia, univariate and multivariate logistic regression analysis were performed. Of the 763 patients included in this study, 496 (65.0%) were found to have reduced muscle mass using criteria from Martin et al. 20 Univariate analysis identified age (>75, 65-75 vs <65 years), ASA status (3 þ 4 vs 1 þ 2), site (colon vs rectum), stage (IV, III, II vs I), NLR (>3 vs <3), and albumin (<35 g/L vs >35 g/L) to be predictors of myopenia. To determine the independent prognostic significance of NLR and albumin on myopenia status, a multivariate logistic regression model analysis was performed. Multivariate analysis included age, ASA, UICC stage, albumin, NLR, and tumor site. Age, NLR, and albumin were independent predictors of myopenia as outlined in Table 4 . A high NLR [odds ratio (OR) ¼ 1.78 (95% confidence interval [CI]: 1.29-2.45), P < 0.001] and low albumin levels [OR ¼ 1.80 (95% CI: 1.17 -2.74), P ¼ 0.007] were independently associated with muscle depletion.
Clinical, Pathological, and Inflammatory Predictors of Myosteatosis
A similar analytical approach was performed to investigate whether SIR parameters were associated with myosteatosis. A total of 643 (83.7%) patients were found to have reduced MA when cutoff values from Martin et al were applied. 20 Univariate analysis showed that sex, age, BMI, site, UICC stage, vascular invasion, NLR, and 
DISCUSSION
This study has demonstrated an association between myopenia and myosteatosis and the presence of an altered SIR, measured as high NLR and low albumin levels, in patients with CRC. It represents data from a large cohort of patients operated electively for primary cancer. The findings support the hypothesis that host SIR may reduce muscularity levels and increase myosteatosis. Furthermore, there were direct relationships between age, sex, tumor site and skeletal muscle mass, and myosteatosis levels. These associations are supported by other publications that identify that myopenia is affected by age through accelerated loss of muscle fiber mass and function. 21 Observational studies have also suggested that both intramyocellular and intermuscular fat may increase with advancing age. 22 A reduction in anabolic stimulation by factors such as sex hormones are known to alter muscle mass, 23 as does comorbidity. 22, 24 In addition to disease-related anorexia, polypharmacy, maldigestion, malabsorption, and dysphagia may contribute to decreased energy intake leading to muscle mass wasting. 25 The negative impact of an altered SIR on CRC outcomes has been recorded previously. 26, 27 The SIR, as defined by a number of inflammation-based prognostic scores, and in particular, the NLR, has been shown to be an independent prognostic marker in CRC. 18, 28 Our group recently demonstrated that for patients with nonmetastatic CRC, a preoperative NLR of more than 3.0 can be an independent prognostic factor for disease-free survival. 29 Routine preoperative NLR measurement in patients undergoing treatment for CRC is a simple and inexpensive means of identifying patients with potentially poorer prognosis and may facilitate clinical decision making. This study indicates that patients with high NLR values and low albumin levels are more likely to have myopenia and myosteatosis, that is, low muscularity levels and low MA. Although this study was not designed to provide an explanation for this, the SIR involves stimulation of a number of mediators that can directly activate catabolic pathways and cause skeletal muscle degradation. 30, 31 Certain study caveats are worthy of mention. First, this was an uncontrolled study despite comprising a relatively large and homogenous data set. Second, CT BC analysis is a static window into a patient's BC changes, but as the standard pretreatment staging modality parameters from this type of analysis, has proven reliable in previous studies. 7, 32 Third, although there is heterogeneity in NLR cutoff values used in the literature, ranging from 3 to 5, we set the threshold as higher than 3 as we have previously identified this value to be an appropriate threshold in our patients. 29 Fourth, electronic Muscle depletion is a common feature of all chronic pathologies but may represent a modifiable risk factor in patients with cancer. The advent of the concept and application ''prehabilitation'' is relevant to the findings of this study. Early identification of low muscularity may permit timely therapeutic intervention before and after surgery. Appetite regulation and physical activity are the major determinants of energy balance and contribute to BC changes. Endurance-and resistance-type exercises may be recommended in muscle-depleted patients to maintain skeletal muscle mass and function, as well as energy balance. Therapeutic interventions using nonselective anti-inflammatory agents, aiming to moderate the inflammatory response of the host, have also been explored. 33 Protein intake may be increased to counteract the anabolic resistance related to inflammation and inactivity. 34, 35 Recent studies have considered the use of (n-3) fatty acids as beneficial in improving the attenuation of lean tissue. 36, 37 
CONCLUSIONS
This study highlights a direct relationship between low muscularity and myosteatosis and the presence of altered SIR in patients with primary operable CRC. Further long-term data on this patient group will help demonstrate the impact of low muscularity and myosteatosis on overall and disease-free survival. Finally, early identification of myopenia and myosteatosis through CT analysis and SIR biomarkers may allow early therapeutic intervention. Future studies should concentrate on metabolic interventions for myopenia and myosteatosis and their impact upon clinical outcomes. 
